US Drug Recall Register
Class II · Moderate risk Terminated Initiated Aug 7, 2018 (8 years ago)

Doxycycline Hyclate USP Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications: manufacturer West-Ward Pharm Corp. recalled these repackaged lots due to failed dissolution results.

What was recalled

Doxycycline Hyclate USP Tablets, 100 mg packaged in a) 2-count bottles, NDC 55289-866-02; b) 6-count bottles, NDC 55289-866-06; c) 7-count bottles, NDC 55289-866-07; d) 10-count bottles, NDC 55289-866-10; e) 14-count bottles, NDC 55289-866-14; f) 20-count bottles, NDC 55289-866-20; g) 28-count bottles, NDC 55289-866-28; h) 30-count bottles, NDC 55289-866-30; i) 120-count bottles, NDC 55289-866-98; j) 300-count bottles, NDC 55289-866-87; k) 400-count bottles, NDC 55289-866-74; Rx only, Packaged By PD-Rx Pharmaceuticals, Oklahoma City, OK 73127.

Recalling firm
PD-Rx Pharmaceuticals, Inc.
NDC code
55289-866-02
Origin
OK, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1127-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Doxycycline recalls

See all
Class II · Moderate risk Ongoing

Doxycycline Hyclate Tablets

Reason Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.

Acella Pharmaceuticals, LLC NDC 42192-501-05 D-0014-2026
Class II · Moderate risk Terminated

Doxycycline

Reason Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

Wedgewood Village Pharmacy, LLC D-1182-2022
Class II · Moderate risk Terminated

Doxycycline Hyclate Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-0430-06 D-1054-2022
Class II · Moderate risk Terminated

Doxycycline Capsules

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 63304-616-50 D-1032-2022
Class II · Moderate risk Terminated

Doxycycline Capsules

Reason CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Cardinal Healthcare NDC 68180-652-08 D-0178-2024